Reperfusion Injury Clinical Trial
— CAPITLOfficial title:
Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL): a First-in-men Study
Verified date | December 2015 |
Source | Universitaire Ziekenhuizen Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to establish the effectiveness of the combined drug approach (anti-thrombin III, infliximab, apotransferrin, human recombinant erythropoietin beta, C1-inhibitor, glutathione, alfa-tocopherol, melatonin and epoprostenol)aimed to reduce ischemia-reperfusion injury during liver transplantation in eligible recipients.
Status | Completed |
Enrollment | 72 |
Est. completion date | August 2019 |
Est. primary completion date | February 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Patients suffering from irreversible liver failure eligible for liver transplantation according to Eurotransplant guidelines. 2. Patients > 18 years of age at time of listing on Eurotransplant waiting list for liver transplantation in University Hospitals Leuven, Belgium. Exclusion Criteria: 1. Patients who refuse to participate in the study. 2. History of hypersensitivity to one/several component(s) of the combined drug approach. 3. Conditions that prevent the use of the combined drug approach: - Administration of heparin at therapeutic dose pre-operatively, - Congestive heart failure, - History of seizure, poorly controlled arterial hypertension, myocardial infarction or stroke in the month preceding the liver transplantation, venous thromboembolic disease, - Unstable angina pectoris, - Sepsis, abcesses or opportunistic infections, - History of infliximab treatment, - Use of vitamin K antagonist anticoagulation. 4. Mental conditions rendering the subject incapable to understand the nature, scope, and consequences of the trial. 5. Combined organ transplantation. 6. Re-transplantation. 7. Patients that are dialysis-dependent prior to the liver transplantation. |
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospitals Leuven | Leuven |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen Leuven |
Belgium,
Monbaliu D, Vekemans K, Hoekstra H, Vaahtera L, Libbrecht L, Derveaux K, Parkkinen J, Liu Q, Heedfeld V, Wylin T, Deckx H, Zeegers M, Balligand E, Buurman W, van Pelt J, Porte RJ, Pirenne J. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg. 2009 Nov;250(5):808-17. doi: 10.1097/SLA.0b013e3181bdd787. — View Citation
Vekemans K, Monbaliu D, Balligand E, Heedfeld V, Jochmans I, Pirenne J, van Pelt J. Improving the function of liver grafts exposed to warm ischemia by the Leuven drug protocol: exploring the molecular basis by microarray. Liver Transpl. 2012 Feb;18(2):206-18. doi: 10.1002/lt.22446. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | log-transformed peak AST | log-transformed peak AST, where peak AST is defined as the highest value of serum AST within 72 hours following liver transplantation | within 72 hours following liver transplantation | |
Secondary | graft loss | graft loss at 3 and 12 months after liver transplantation | 3 and 12 months after liver transplantation | |
Secondary | recipient death | recipient death at 3 and 12 months after liver transplantation | 3 and 12 months after liver transplantation | |
Secondary | early graft dysfunction | early graft dysfunction as defined by Olthoff | within first 7 days | |
Secondary | Incidence of biliary strictures | Incidence of biliary strictures within 12 months post transplantation by MRCP (magentic resonance cholangiopancreatography) | within 12 months post transplantation | |
Secondary | IRI score | IRI score during transplantation, 1 week and 1 year after liver transplantation by using the Suzuki score and Monbaliu et al. | during transplantation, 1 week and 1 year after | |
Secondary | Graft rejecton | a liver biopsy will be taken after transplantation and in cas of clinical suspicion of acute rejection | till 1 year after transplantation | |
Secondary | Surgical complications | the ranking of surgical complications will be done by using Clavien-Dindo classification | within 30 days after liver transplantation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01944605 -
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
|
N/A | |
Completed |
NCT00778323 -
Clinical Trial of Remote Preconditioning in Patients Undergoing Cervical Decompression Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT00529607 -
Diagnostics for the Reperfusion Injury Following MI
|
N/A | |
Completed |
NCT00994981 -
Magnesium Administration in Liver Transplantation and Reperfusion Injury
|
Phase 4 | |
Completed |
NCT02286544 -
Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02731651 -
Effect of Pneumoperitoneum on Human Ovary
|
N/A | |
Active, not recruiting |
NCT00189007 -
Antenatal Allopurinol During Fetal Hypoxia
|
Phase 3 | |
Completed |
NCT01167569 -
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
|
Phase 4 | |
Completed |
NCT00246740 -
Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting
|
Phase 2 | |
Enrolling by invitation |
NCT05725694 -
Acute Ischaemic STROKE: From LAboratory to the Patient's BED
|
||
Completed |
NCT00402506 -
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
|
Phase 3 | |
Completed |
NCT03176823 -
Remote Ischemic Conditioning as a Treatment for Traumatic Brain Injury
|
N/A | |
Completed |
NCT02512640 -
Comparison of Oxidative Stress Changes in Different Ventilation Strategies During Gynecologic Laparoscopic Surgery
|
N/A | |
Recruiting |
NCT05574296 -
Hydrogen's Feasibility and Safety as a Therapy in ECPR
|
Phase 1 | |
Active, not recruiting |
NCT02127996 -
GLP-1 Loading During Elective Percutaneous Coronary Intervention
|
Phase 2 | |
Terminated |
NCT02394405 -
Myocardial and Renal Dysfunction by Oxidative Stress Caused by Cardiac Surgery
|
||
Suspended |
NCT02850471 -
Pulmonary Protection of Transcutaneous Electrical Acupoint Stimulation in Gynecologic Laparoscopic Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT00516711 -
Role of Volatile Anesthetics for Hepatic Protection
|
N/A | |
Terminated |
NCT04316468 -
Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation
|
||
Not yet recruiting |
NCT05676957 -
Reperfusion With Hypothermia in Acute Ischemic Stroke
|
N/A |